News Archive
ConjuChem Biotechnologies (TSX:CJB) today announced financial results for the third quarter of fiscal 2009, ended July 31, 2009.
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Promotoras — volunteer "health promoters" … carry messages of health and wellness to their peers, mostly Spanish-speaking Mexicans in South Philadelphia. As the minority group least likely to have a primary-care doctor and with nearly half living beneath the poverty line, Latinos, especially recent immigrants, have challenged doctors for decades.
Forbes features two interviews with global health leaders. Contributor Rahim Kanani spoke with Seth Berkley, CEO of the GAVI Alliance, about GAVI's impact, innovation, public-private collaboration, and leadership and responsibility. In the interview, Berkley said vaccinating children not only protects them from disease, but it "protects families and whole communities.
Despite the remarkable successes of immune-based treatments for cancer, not everyone responds to these approaches and relapses do occur.
› Verified 9 days ago